Status:
COMPLETED
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Nephrogenic Systemic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that th...
Eligibility Criteria
Inclusion
- Male or female subjects 18 years of age or older.
- Willing and able to understand and provide oral informed consent.
- Able to complete study and comply with study procedures.
Exclusion
- Subject is unable to provide oral consent.
- Psychiatric or other conditions which might, in the opinion of the Principal Investigator, interfere with study evaluations or pose a risk to subject safety during the study.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00869479
Start Date
March 1 2009
End Date
September 1 2010
Last Update
December 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114